Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Baynes

Showing results (11-20 of 192) with videos related to

Pageof 20
Sort By:
Clinical Chemistry and Laboratory Medicine|August 14, 2013
Frontiers in research on the Maillard reaction in aging and chronic diseaseJohn W Baynes, P Gillery
Clinical Chemistry and Laboratory Medicine|April 25, 2013
Chelation therapy for the management of diabetic complications: a hypothesis and a proposal for clinical laboratory assessment of metal ion homeostasis in plasmaNorma Frizzell, John W Baynes
The Journal of Biological Chemistry|October 10, 1976
Effect of glycosylation on the in vivo circulating half-life of ribonucleaseJ W Baynes, F Wold
Future Medicinal Chemistry|June 26, 2013
Chelation therapy: overlooked in the treatment and prevention of diabetes complications?Norma Frizzell, John W Baynes
Diabetes|January 19, 1999
Role of oxidative stress in diabetic complications: a new perspective on an old paradigmJ W Baynes, S R Thorpe
Biochimica Et Biophysica Acta|December 13, 2005
The anti-cancer drug, doxorubicin, causes oxidant stress-induced endothelial dysfunctionMatthew B Wolf, John W Baynes
Drugs & Aging|August 1, 1996
Role of the Maillard reaction in diabetes mellitus and diseases of agingS R Thorpe, J W Baynes
Archives of Biochemistry and Biophysics|February 1, 1981
Identification of the sites of albumin catabolism in the ratJ W Baynes, S R Thorpe
Experimental Diabetes Research|April 25, 2009
The metal chelators, trientine and citrate, inhibit the development of cardiac pathology in the Zucker diabetic ratJohn W Baynes, David B Murray
Amino Acids|December 9, 2003
Maillard reaction products in tissue proteins: new products and new perspectivesS R Thorpe, J W Baynes
Pageof 20

Showing results (11-20 of 192) with videos related to

Sort By:
Pageof 20
Clinical Chemistry and Laboratory Medicine|August 14, 2013
Frontiers in research on the Maillard reaction in aging and chronic diseaseJohn W Baynes, P Gillery
Clinical Chemistry and Laboratory Medicine|April 25, 2013
Chelation therapy for the management of diabetic complications: a hypothesis and a proposal for clinical laboratory assessment of metal ion homeostasis in plasmaNorma Frizzell, John W Baynes
The Journal of Biological Chemistry|October 10, 1976
Effect of glycosylation on the in vivo circulating half-life of ribonucleaseJ W Baynes, F Wold
Future Medicinal Chemistry|June 26, 2013
Chelation therapy: overlooked in the treatment and prevention of diabetes complications?Norma Frizzell, John W Baynes
Diabetes|January 19, 1999
Role of oxidative stress in diabetic complications: a new perspective on an old paradigmJ W Baynes, S R Thorpe
Biochimica Et Biophysica Acta|December 13, 2005
The anti-cancer drug, doxorubicin, causes oxidant stress-induced endothelial dysfunctionMatthew B Wolf, John W Baynes
Drugs & Aging|August 1, 1996
Role of the Maillard reaction in diabetes mellitus and diseases of agingS R Thorpe, J W Baynes
Archives of Biochemistry and Biophysics|February 1, 1981
Identification of the sites of albumin catabolism in the ratJ W Baynes, S R Thorpe
Experimental Diabetes Research|April 25, 2009
The metal chelators, trientine and citrate, inhibit the development of cardiac pathology in the Zucker diabetic ratJohn W Baynes, David B Murray
Amino Acids|December 9, 2003
Maillard reaction products in tissue proteins: new products and new perspectivesS R Thorpe, J W Baynes
Pageof 20